Trials / Completed
CompletedNCT03460834
Asthma and Obesity: Observational
Obesity and Asthma: Unveiling Metabolic and Behavioral Pathways
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 333 (estimated)
- Sponsor
- Icahn School of Medicine at Mount Sinai · Academic / Other
- Sex
- All
- Age
- 21 Years – 64 Years
- Healthy volunteers
- Not accepted
Summary
Obesity is associated with poor asthma control and greater healthcare utilization and costs. In this study the researchers will examine the biologic and behavioral interrelationships between these conditions and their impact on outcomes. Towards this end, the researchers will conduct an observational prospective cohort study of 400 obese asthmatic patients treated at institutions in New York City and Denver, and develop and pilot test educational and counseling modules that take an integrated approach to asthma and obesity self-management support.
Detailed description
The objective of this study is to examine novel biological and behavioral pathways that may explain the association of obesity with asthma morbidity, and develop and pilot test educational and counseling modules, based on self-regulation theory, that take an integrated approach to asthma and obesity self-management support. The Specific Aims are to: 1. Compare the longitudinal relationship between L-arginine/ADMA balance and morbidity (lung function, asthma control, acute resource utilization, and quality of life) between obese adults with late onset asthma vs. (a) obese adults with early onset asthma and non-obese asthmatics with early (b) or late (c) onset disease. Age of asthma onset is as categorized as early when developed ≤12 years of age or late when developed \>12 years of age. 2. Evaluate the interrelationship between obesity- and asthma-related illness beliefs, and the impact of cognitive function, on patients' management of these conditions over time
Conditions
Timeline
- Start date
- 2016-05-01
- Primary completion
- 2021-04-30
- Completion
- 2021-04-30
- First posted
- 2018-03-09
- Last updated
- 2021-05-06
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT03460834. Inclusion in this directory is not an endorsement.